Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kotronen

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Diabetes Care|July 25, 2013
Is there evidence to support use of premixed or prandial insulin regimens in insulin-naive or previously insulin-treated type 2 diabetic patients?Hannele Yki-Järvinen, Anna Kotronen
Arteriosclerosis, Thrombosis, and Vascular Biology|August 11, 2007
Fatty liver: a novel component of the metabolic syndromeAnna Kotronen, Hannele Yki-Järvinen
The Journal of Clinical Endocrinology and Metabolism|October 25, 2007
Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin dosesLeena Juurinen, Anna Kotronen, Marit Granér, et al.
Current Opinion in Lipidology|May 19, 2010
Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 proteinStefano Romeo, Isabel Huang-Doran, Marco Giorgio Baroni, et al.
Gastroenterology|May 14, 2008
Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetesAnna Kotronen, Leena Juurinen, Mirja Tiikkainen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 18, 2008
Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivityAnna Kotronen, Moira Lewitt, Kerstin Hall, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 27, 2007
Effect of liver fat on insulin clearanceAnna Kotronen, Satu Vehkavaara, Anneli Seppälä-Lindroos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2007
Liver fat in the metabolic syndromeAnna Kotronen, Jukka Westerbacka, Robert Bergholm, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 9, 2010
From the metabolic syndrome to NAFLD or vice versa?Ester Vanni, Elisabetta Bugianesi, Anna Kotronen, et al.
Diabetes Care|October 16, 2007
Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjectsAnna Kotronen, Leena Juurinen, Antti Hakkarainen, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Diabetes Care|July 25, 2013
Is there evidence to support use of premixed or prandial insulin regimens in insulin-naive or previously insulin-treated type 2 diabetic patients?Hannele Yki-Järvinen, Anna Kotronen
Arteriosclerosis, Thrombosis, and Vascular Biology|August 11, 2007
Fatty liver: a novel component of the metabolic syndromeAnna Kotronen, Hannele Yki-Järvinen
The Journal of Clinical Endocrinology and Metabolism|October 25, 2007
Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin dosesLeena Juurinen, Anna Kotronen, Marit Granér, et al.
Current Opinion in Lipidology|May 19, 2010
Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 proteinStefano Romeo, Isabel Huang-Doran, Marco Giorgio Baroni, et al.
Gastroenterology|May 14, 2008
Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetesAnna Kotronen, Leena Juurinen, Mirja Tiikkainen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 18, 2008
Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivityAnna Kotronen, Moira Lewitt, Kerstin Hall, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 27, 2007
Effect of liver fat on insulin clearanceAnna Kotronen, Satu Vehkavaara, Anneli Seppälä-Lindroos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2007
Liver fat in the metabolic syndromeAnna Kotronen, Jukka Westerbacka, Robert Bergholm, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 9, 2010
From the metabolic syndrome to NAFLD or vice versa?Ester Vanni, Elisabetta Bugianesi, Anna Kotronen, et al.
Diabetes Care|October 16, 2007
Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjectsAnna Kotronen, Leena Juurinen, Antti Hakkarainen, et al.
Pageof 4